#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Acute promyelocytic leukaemia Mantle cell lymphoma stage II Cardiac sarcoidosis Epilepsy Sarcoidosis Mitochondrial encephalomyopathy Amyotrophic lateral sclerosis gene carrier Soft tissue sarcoma Immune-mediated renal disorder B-cell lymphoma recurrent Congenital growth hormone deficiency Myelodysplastic syndrome/myeloproliferative neoplasm overlap syndrome Hereditary optic atrophy Neuropathic arthropathy Pericarditis More trials…

    Learn about Rare Diseases

    Primary mediastinal large B-cell lymphoma – Life with Disease Hairy cell leukaemia – Treatment Urea cycle disorder – Diagnostics Shprintzen-Goldberg syndrome – Life with Disease Cystic fibrosis lung Bronchiolitis obliterans syndrome – Trials in Disease Kearns-Sayre syndrome Alternating hemiplegia of childhood – Treatment Waldenstrom’s macroglobulinaemia recurrent – Treatment Isodicentric chromosome 15 syndrome – Trials in Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Bi-1910 OXYBUTYNIN HYDROCHLORIDE Florbetaben (18F) Ciltacabtagene Autoleucel Lenacapavir SOVATELTIDE Lithium Sulphate, Anhydrous Gelatin HLX43 6QC-ICG Hydroxyzine Hydrochloride ZILEBESIRAN Azd3427 Salbutamol Sulfate Ph. Eur. Sasanlimab MEGESTROL ACETATE Lixisenatide Irbesartan Betamethasone Sodium Phosphate Etoposide Phosphate More therapies…

    Learn about Your Condition

    Coronary artery disease Dyslipidaemia Nervous system disorder Neoplasm Tuberous sclerosis complex Meningioma Chronic kidney disease Papulopustular rosacea Kawasaki's disease Gastric cancer recurrent Acute lymphocytic leukaemia Ligament operation Myasthenia gravis Head and neck cancer Metastatic malignant melanoma More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Thrombocytopenia

  • Study of romiplostim given before heart surgery in patients with low platelet counts to improve blood clotting after surgery

    Recruiting

    2 1 1
    Investigated Diseases:
    • Thrombocytopenia
    Investigated Drugs:
    • Romiplostim
    • Sodium Chloride
    France

  • Study on the Effectiveness and Safety of Human Normal Immunoglobulin (IV) for Adults with Chronic Immune Thrombocytopenia

    Recruiting

    3 1 1
    Investigated Diseases:
    • Thrombocytopenia
    Investigated Drugs:
    • Human Normal Immunoglobulin (Iv)
    Czechia Germany Italy Romania Spain

  • Study on the Effectiveness and Safety of Selinexor for Patients with Myelofibrosis and Moderate Thrombocytopenia Who Have Not Used JAK Inhibitors

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Thrombocytopenia
    • Myelofibrosis
    Investigated Drugs:
    • Netupitant
    • Pacritinib
    • Ondansetron
    Belgium Bulgaria Czechia Denmark France Germany +7

  • A study to compare the absorption of eltrombopag olamine in healthy volunteers to ensure the tablets work the same way for patients with thrombocytopenia or aplastic anemia.

    Not recruiting

    1 1 1 1
    Investigated Diseases:
    • Aplastic anaemia
    • Thrombocytopenia
    Portugal

  • Study of romiplostim for treating low platelet counts caused by chemotherapy in adults with non-small cell lung cancer, ovarian cancer, or breast cancer

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Thrombocytopenia
    • Ovarian cancer
    • Breast cancer
    Investigated Drugs:
    • Romiplostim
    Greece Poland Portugal Romania Spain

  • A Study Comparing Eltrombopag Tablets in Healthy Volunteers to Test if Two Forms of the Medicine Work the Same Way in the Body After Taking with Food

    Not recruiting

    1 1 1 1
    Investigated Diseases:
    • Aplastic anaemia
    • Thrombocytopenia
    Portugal

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!